Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein synthesis in bacteria refers to the coordinated process by which bacterial cells translate genetic information encoded in mRNA into functional proteins, using a specialized macromolecular complex called the ribosome[1][3][9]. The bacterial ribosome consists of two subunits (30S and 50S, forming the 70S ribosome) and is composed of ribosomal RNA and proteins, providing the sites for mRNA decoding and peptide bond formation[3][9]. The process occurs in three main stages: initiation (involving assembly of the ribosome at the start codon with initiator fMet-tRNA), elongation (successive addition of amino acids via tRNA and peptide bond formation), and termination (release of the completed polypeptide when a stop codon is reached), with a subsequent recycling step[1][9]. All these stages are potential targets for antibiotics and are mechanistically distinct from eukaryotic translation, making the bacterial ribosome one of the most validated and therapeutically important antibacterial drug targets[9][3]. Classic antibiotic classes, such as aminoglycosides and macrolides, inhibit distinct functional centers of the ribosome, often by stalling the machinery or causing misreading of mRNA[9]. Because the "target" is a complex and not a single protein or gene, the correct canonical assignment in structured databases would be to the "bacterial ribosome" or its subunits; "protein synthesis in bacteria" is a process, not a discrete molecule. For research and clinical purposes, the bacterial ribosome complex and its associated translation machinery are the true molecular targets.
Inhibition of ribosomal subunit function, Blockade of peptide bond formation, Mistaken codon recognition, Prevention of tRNA translocation, Inhibition of initiation/elongation/termination steps
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein synthesis machinery (bacterial).